Enhertu (Fam-trastuzumab-deruxtecan-nxki) – Revolutionizing treatment paradigm for HER2-Low breast cancer

Detalles Bibliográficos
Autores principales: Siddiqui, Tasmiyah, Rani, Payal, Ashraf, Tayyaba, Ellahi, Aayat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577648/
https://www.ncbi.nlm.nih.gov/pubmed/36268293
http://dx.doi.org/10.1016/j.amsu.2022.104665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577648/
https://www.ncbi.nlm.nih.gov/pubmed/36268293
http://dx.doi.org/10.1016/j.amsu.2022.104665

Ejemplares similares